EACC

Coronavirus: Commission reaches first agreement on a potential vaccine

Today, the European Commission has reached a first agreement with the pharmaceutical company AstraZeneca to purchase a potential vaccine against COVID-19 as well as to donate to lower and middle income countries or re-direct to other European countries. This is following the positive steps regarding the conclusion of exploratory talks with Sanofi-GSK announced on 31 July and with Johnson & Johnson on 13 August. Once the vaccine has proven to be safe and effective against COVID-19, the Commission now has agreed the basis for a contractual framework for the purchase of 300 million doses of the AstraZeneca vaccine, with an option to purchase 100 million more, on behalf of EU Member States. The Commission continues discussing similar agreements with other vaccine manufacturers.
Ursula von der Leyen, President of the European Commission, said: “The European Commission’s intense negotiations continue to achieve results. Today’s agreement is the first cornerstone in implementing the European Commission’s Vaccines Strategy. This strategy will enable us to provide future vaccines to Europeans, as well as our partners elsewhere in the world.”
Stella Kyriakides, Commissioner for Health and Food Safety, said: “Today, after weeks of negotiations, we have the first EU advance purchase agreement for a vaccine candidate. I would like to thank AstraZeneca for its constructive engagement on this important agreement for our citizens. We will continue to work tirelessly to bring more candidates into a broad EU vaccines portfolio. A safe and effective vaccine remains the surest exit strategy to protect our citizens and the rest of the world from the coronavirus.”
The agreement approved today will be financed with the Emergency Support Instrument, which has funds dedicated to the creation of a portfolio of potential vaccines with different profiles and produced by different companies.
AstraZeneca’s vaccine candidate is already in large-scale Phase II/III Clinical Trials after promising results in Phase I/II concerning safety and immunogenicity.
The decision to support the vaccine proposed by AstraZeneca is based on a sound scientific approach and the technology used (a non-replicative recombinant chimpanzee adenovirus-based vaccine ChAdOx1), speed at delivery at scale, cost, risk sharing, liability and the production capacity able to supply the whole of the EU, among others.
The regulatory processes will be flexible but remain robust. Together with the Member States and the European Medicines Agency, the Commission will use existing flexibilities in the EU’s regulatory framework to accelerate the authorisation and availability of successful vaccines against COVID-19. This includes an accelerated procedure for authorisation and flexibility in relation to labelling and packaging.
Background
The European Commission presented on 17 June a European strategy to accelerate the development, manufacturing and deployment of effective and safe vaccines against COVID-19. In return for the right to buy a specified number of vaccine doses in a given timeframe, the Commission would finance part of the upfront costs faced by vaccines producers in the form of Advance Purchase Agreements. Funding provided would be considered as a down-payment on the vaccines that will actually be purchased by Member States.
Since the high cost and high failure rate make investing in a COVID-19 vaccine a high-risk decision for vaccine developers, these agreement will therefore allow investments to be made that otherwise would simply probably not happen.
The European Commission is also committed to ensuring that everyone who needs a vaccine gets it, anywhere in the world and not only at home. No one will be safe until everyone is safe. This is why it has raised almost €16 billion since 4 May 2020 under the Coronavirus Global Response, the global action for universal access to tests, treatments and vaccines against coronavirus and for the global recovery.
Compliments of the European Commission.

EACC

U.S. Federal Reserve Board announces individual large bank capital requirements, which will be effective on October 1

Following its stress tests earlier this year, the Federal Reserve Board on Monday announced individual large bank capital requirements, which will be effective on October 1.
Under its framework for large banks—those with more than $100 billion in total assets—capital requirements are in part determined by stress test results, which provide a risk-sensitive and forward-looking assessment of capital needs. The below table shows the total common equity tier 1, or CET1, capital requirements for each large bank, which is comprised of several components, including:
Minimum capital requirements, which are the same for each firm and are 4.5 percent;
The stress capital buffer, or SCB, which is determined from the stress test results, and is at least 2.5 percent; and
If applicable, a capital surcharge for global systemically important banks, or GSIBs, which is at least 1.0 percent.
Capital buffers, such as the SCB and GSIB surcharge, are different than minimum capital requirements for each firm. The Federal Reserve supports banking organizations that choose to use their capital buffers to lend to households and businesses and undertake other supportive actions in a safe and sound manner. When using their buffers, banking organizations may make capital distributions up to prescribed limits, which include automatic limitations in the capital framework, as well as any additional limitations determined by the Board.
Also on Monday, the Board affirmed the stress test results for five firms that requested reconsideration. Those firms are BMO Financial Corporation, Capital One Financial Corporation, Citizens Financial Group, Inc., The Goldman Sachs Group Inc., and Regions Financial Corporation.
The reconsideration process involved an independent group—separate from the stress testing group—that analyzed and evaluated the results. The results were checked for errors and to ensure that the stress test models, which project the loan losses for banks, worked as intended and were consistent with the Board’s stress test framework.
As the Board has done with input gained from a variety of stakeholders and events, including its annual stress test model symposium, the Board will assess the information learned from the reconsideration process and use it to continue improving its stress testing methodology.
Bank
Minimum CET1 Capital Ratio
Stress Capital Buffer
GSIB Surcharge*
CET1 Capital Requirement
Ally Financial Inc.
4.5%
3.5%
n/a
8.0%
American Express Corporation
4.5%
2.5%
n/a
7.0%
Bank of America
4.5%
2.5%
2.5%
9.5%
The Bank of New York Mellon Corporation
4.5%
2.5%
1.5%
8.5%
Barclays US LLC
4.5%
5.0%
n/a
9.5%
BMO Financial Corp
4.5%
6.0%
n/a
10.5%
BNP Paribas USA, Inc.
4.5%
6.4%
n/a
10.9%
Capital One Financial Corporation
4.5%
5.6%
n/a
10.1%
Citigroup Inc.
4.5%
2.5%
3.0%
10.0%
Citizens Financial Group, Inc.
4.5%
3.4%
n/a
7.9%
Credit Suisse Holdings USA, Inc.
4.5%
6.9%
n/a
11.4%
DB USA Corporation
4.5%
7.8%
n/a
12.3%
Discover Financial Services
4.5%
3.5%
n/a
8.0%
DWS USA Corporation
4.5%
2.5%
n/a
7.0%
Fifth Third Bancorp
4.5%
2.5%
n/a
7.0%
The Goldman Sachs Group, Inc.
4.5%
6.7%
2.5%
13.7%
HSBC North America Holdings Inc.
4.5%
5.7%
n/a
10.2%
Huntington Bancshares Incorporated
4.5%
2.5%
n/a
7.0%
JPMorgan Chase & Co.
4.5%
3.3%
3.5%
11.3%
KeyCorp
4.5%
2.5%
n/a
7.0%
M&T Bank Corporation
4.5%
2.5%
n/a
7.0%
Morgan Stanley
4.5%
5.9%
3.0%
13.4%
MUFG Americas Holdings Corporation
4.5%
4.4%
n/a
8.9%
Northern Trust Corporation
4.5%
2.5%
n/a
7.0%
The PNC Financial Services Group, Inc.
4.5%
2.5%
n/a
7.0%
RBC US Group Holdings LLC
4.5%
3.6%
n/a
8.1%
Regions Financial Corporation
4.5%
3.0%
n/a
7.5%
Santander Holdings USA, Inc.
4.5%
2.5%
n/a
7.0%
State Street Corporation
4.5%
2.5%
1.0%
8.0%
TD Group US Holdings LLC
4.5%
2.5%
n/a
7.0%
Truist Financial Corporation
4.5%
2.7%
n/a
7.2%
UBS Americas Holdings LLC
4.5%
6.7%
n/a
11.2%
U.S. Bancorp
4.5%
2.5%
n/a
7.0%
Wells Fargo & Company
4.5%
2.5%
2.0%
9.0%
*The GSIB surcharge is updated annually in the first quarter.
For media inquiries, call 202-452-2955
Compliments of the U.S. Federal Reserve Board.

EACC

U.S. Federal Reserve Board announces revised pricing for its Municipal Liquidity Facility

The Federal Reserve Board on Tuesday announced revised pricing for its Municipal Liquidity Facility (MLF). The revised pricing reduces the interest rate spread on tax-exempt notes for each credit rating category by 50 basis points and reduces the amount by which the interest rate for taxable notes is adjusted relative to tax-exempt notes.
Today’s changes will ensure the MLF continues to provide an effective backstop to assist U.S. states and local governments as they weather the pandemic.
The MLF was established under Section 13(3) of the Federal Reserve Act, with approval of the Treasury Secretary. It offers up to $500 billion in lending to states and municipalities to help manage cash flow stresses caused by the coronavirus pandemic.
For media inquiries, call 202-452-2955.
Term sheet: Municipal Liquidity Facility (PDF)
Compliments of the U.S. Federal Reserve Board.

EACC

Coronavirus: 23 new research projects to receive €128 million in EU funding

The Commission will support 23 new research projects with €128 million in response to the continuing coronavirus pandemic. The funding under Horizon 2020, the EU’s research and innovation programme, is part of the Commission’s €1.4 billion pledge to the Coronavirus Global Response initiative, launched by President Ursula von der Leyen in May 2020.
The 23 projects shortlisted for funding involve 347 research teams from 40 countries, including 34 participants from 16 countries outside of the EU. The funding will enable researchers to address the pandemic and its consequences by strengthening the industrial capacity to manufacture and deploy readily available solutions, develop medical technologies and digital tools, improve understanding of behavioural and socio-economic impacts of the pandemic, and to learn from large groups of patients (cohorts) across Europe. These research actions complement earlier efforts to develop diagnostics, treatments and vaccines.
Mariya Gabriel, Commissioner for Innovation, Research, Culture, Education and Youth, said: “Emergency funding from Horizon 2020 will enable researchers to rapidly develop solutions with and for patients, care workers, hospitals, local communities and companies. The results will help them to better cope with and survive coronavirus infections. It’s encouraging to see the research community mobilise so rapidly and strongly.”
Thierry Breton, Commissioner for Internal Market, added: “The excellent response to this call shows the wealth of new ideas to tackle coronavirus, including new digital health solutions. Digital solutions and technologies enabled us to stay connected and interact with each other during the confinement. They will also be an essential part of the long-term response to this virus and to increasing our resilience.”
The Commission is currently negotiating grant agreements with the selected beneficiaries. The new projects will cover:
Repurposing manufacturing for rapid production of vital medical supplies and equipment needed for testing, treatment and prevention – for instance using injection moulding and additive manufacturing (3-D printing), adaptive production and supply chain methods, and repurposing manufacturing as a service network for fast reaction.
Developing medical technologies and digital tools to improve detection, surveillance and patients’ care – for example through the development of new devices for faster, cheaper and easier diagnosis (including remotely) plus new technologies to protect healthcare workers.
Analysing behavioural and socio-economic impacts of the responses of government and public health systems, for instance on mental health, including gender-specific aspects in risk factors and the socioeconomic burden, to develop inclusive guidance for policymakers and health authorities and enhance preparedness for future similar events.
Learning from large groups of patients (cohorts) by connecting existing cohorts in the EU and beyond to assess their exposure to certain risk factors to better understand the possible causes of disease in order to improve responsiveness to the virus and future public health threats.
Enhancing collaboration of existing EU and international cohorts by networking research institutions that are collecting data on patient care to enable studies into patient’s characteristics, risk factors, safety and effectiveness of treatments and potential strategies against coronavirus.
Background
This second emergency request for expressions of interest, launched by the Commission on 19 May 2020 gave researchers just under 4 weeks to prepare collaborative research projects. The research community mobilised rapidly. Research proposals were fast-tracked through evaluation by independent experts, enabling the Commission to shortlist a number of projects of excellent scientific quality and high potential impact. Although funding is conditional on a final Commission decision and the signature of the Horizon 2020 Grant Agreement, the research teams can already start their work.
Many of the 23 short-listed projects have an international dimension beyond the EU and associated countries, with 34 organisations involved from 16 countries outside of the EU including countries associated to the Horizon 2020 programme (Bosnia-Herzegovina, Israel, Norway, Serbia, Switzerland and Turkey) and third countries (Argentina, Australia, Brazil, Columbia, Congo, Gabon, India, Korea, South Africa and the United States).
This new special call under Horizon 2020 complements earlier actions to support 18 projects with €48.2 million to develop diagnostics, treatments, vaccines and preparedness for epidemics, as well as the €117 million invested in 8 projects on diagnostics and treatments through the Innovative Medicines Initiative, and measures to support innovative ideas through the European Innovation Council. It implements Action 3 of the ERAvsCorona Action Plan, a working document resulting from dialogues between the Commission and national institutions.
Compliments of the European Commission.

EACC

EU Commission: Getting ready for the end of the Brexit transition period

The Brexit transition ends December 31, 2020. In 5 months, the UK leaves Single Market and Customs Union. Changes are inevitable, with or without agreement on the new partnership. Companies and citizens must get ready.
Even if the European Union and the United Kingdom conclude a highly ambitious partnership covering all areas agreed in the Political Declaration by the end of 2020, the United Kingdom’s withdrawal from the EU acquis, the internal market and the Customs Union, at the end of the transition period will inevitably create barriers to trade and cross-border exchanges that do not exist today.
There will be broad and far-reaching consequences for public administrations, businesses and citizens as of 1 January 2021, regardless of the outcome of negotiations. These changes are unavoidable and stakeholders must make sure they are ready for them.
To assist, the Commission is reviewing – and where necessary updating – the over 100 sector-specific stakeholder preparedness notices it published during the Article 50 negotiations with the United Kingdom.
Those notices that have already been updated as ‘notices for readiness’ can be found using the following link: Getting ready for the end of the transition period
Compliments of the European Commission.

EACC

Lifting of travel restrictions: EU Council reviews the list of third countries

Following a review under the recommendation on the gradual lifting of the temporary restrictions on non-essential travel into the EU, the Council updated the list of countries for which travel restrictions should be lifted. As stipulated in the Council recommendation, this list will continue to be reviewed regularly and, as the case may be, updated.
Based on the criteria and conditions set out in the recommendation, as from 8 August member states should gradually lift the travel restrictions at the external borders for residents of the following third countries:
Australia
Canada
Georgia
Japan
New Zealand
Rwanda
South Korea
Thailand
Tunisia
Uruguay
China, subject to confirmation of reciprocity
Residents of Andorra, Monaco, San Marino and the Vatican should be considered as EU residents for the purpose of this recommendation.
The criteria to determine the third countries for which the current travel restriction should be lifted cover in particular the epidemiological situation and containment measures, including physical distancing, as well as economic and social considerations. They are applied cumulatively.
Regarding the epidemiological situation, third countries listed should meet the following criteria, in particular:
number of new COVID-19 cases over the last 14 days and per 100 000 inhabitants close to or below the EU average (as it stood on 15 June 2020)
stable or decreasing trend of new cases over this period in comparison to the previous 14 days
overall response to COVID-19 taking into account available information, including on aspects such as testing, surveillance, contact tracing, containment, treatment and reporting, as well as the reliability of the information and, if needed, the total average score for International Health Regulations (IHR). Information provided by EU delegations on these aspects should also be taken into account.
Reciprocity should also be taken into account regularly and on a case-by-case basis.
For countries where travel restrictions continue to apply, the following categories of people should be exempted from the restrictions:
EU citizens and their family members
long-term EU residents and their family members
travellers with an essential function or need, as listed in the Recommendation.
Schengen associated countries (Iceland, Lichtenstein, Norway, Switzerland) also take part in this recommendation.
Next steps
The Council recommendation is not a legally binding instrument. The authorities of the member states remain responsible for implementing the content of the recommendation. They may, in full transparency, lift only progressively travel restrictions towards countries listed.
A Member State should not decide to lift the travel restrictions for non-listed third countries before this has been decided in a coordinated manner.
This list of third countries should continue to be reviewed regularly and may be further updated by the Council, as the case may be, after close consultations with the Commission and the relevant EU agencies and services following an overall assessment based on the criteria above.
Travel restrictions may be totally or partially lifted or reintroduced for a specific third country already listed according to changes in some of the conditions and, as a consequence, in the assessment of the epidemiological situation. If the situation in a listed third country worsens quickly, rapid decision-making should be applied.
Background
On 16 March 2020, the Commission adopted a communication recommending a temporary restriction of all non-essential travel from third countries into the EU for one month. EU heads of state or government agreed to implement this restriction on 17 March. The travel restriction was extended for a further month respectively on 8 April 2020 and 8 May 2020.
On 11 June the Commission adopted a communication recommending the further extension of the restriction until 30 June 2020 and setting out an approach for a gradual lifting of the restriction on non-essential travel into the EU as of 1 July 2020.
On 30 June the Council adopted a recommendation on the gradual lifting of the temporary restrictions on non-essential travel into the EU, including an initial list of countries for which member states should start lifting the travel restrictions at the external borders. This list was updated on 16 July and 30 July.
Compliments of the European Council.

Read More
EACC

COVID-19 Response in Emerging Market Economies: Conventional Policies and Beyond

The economic impact of the COVID-19 pandemic on emerging market economies far exceeded that of the global financial crisis. Unlike previous crises, the response has been decisive just like in advanced economies. Yet, conventional policies are reaching their limit and unorthodox policies are not without risks.
A pandemic still unfolding
COVID-19 is still to play out fully in the emerging market universe (see chart for country list), posing risks to both people and economies. While countries such as China, Uruguay, and Vietnam have managed to contain the virus, others such as Brazil, India, and South Africa continue to grapple with a rise in infections.
Emerging markets are likely to face an uphill battle.
The economic impact has been even more severe as emerging market economies were buffeted by multiple shocks. Compounding the effects of domestic containment measures has been a decline in external demand. Particularly hit are tourism-dependent countries due to a decline in travel and oil exporters as commodity prices plummeted. With global trade and oil prices projected to drop by more than 10 percent and 40 percent respectively, emerging market economies are likely to face an uphill battle. This is even as capital outflows have stabilized and sovereign spreads retreated compared to the sharply volatile market conditions seen in March.
Not surprisingly, the IMF’s latest June World Economic Outlook Update projects emerging market economies to shrink by 3.2 percent this year—the largest drop for this group on record. By way of comparison, in the global financial crisis, growth for the group took a significant hit but still bottomed out at a positive 2.6 percent in 2009.
A decisive policy response
The crisis would have been worse still without the extraordinary policy support. For sure, decisive policy actions in advanced economies led to a turnaround in market conditions that allowed emerging market economies to resume external financing efforts in April and May, which contributed to record levels of bond issuance so far this year—to the tune of $124 billion as of the end of June. But not all countries have seen improved fortunes. Fuel exporters, frontier countries and those with high debt are experiencing a greater financial shock that pushed up borrowing costs, or even worse, denied them further access to markets.
Policy support by advanced economies provided emerging market economy policymakers with wiggle room to soften the economic blow. Unlike previous episodes, where emerging market economies tended to tighten policy to avoid rapid capital outflows and the inflationary effect of exchange rate depreciations, the current crisis has seen emerging market economies’ policy reaction more in line with that of advanced economies (see the IMF’s policy tracker). Most emerging market economies used reserve buffers more sparingly and allowed exchange rates to adjust to a larger extent, while many countries injected liquidity as needed to ensure market functioning. Countries like Poland and Indonesia further eased macroprudential policies to support credit.

Image courtesy of the IMF.
Like their more advanced peers, many emerging market economies, including Thailand, Mexico, and South Africa, eased monetary policy during this cycle. In a few cases, limited room to cut policy rates further and distressed market conditions induced use of unconventional monetary policy measures for the first time. These included purchases of government and corporate bonds, although the amounts remain modest so far compared to the larger advanced economies. Conversely, the use of capital flow measures to deter capital outflows has been quite limited so far.
A similar picture is evident on the fiscal policy front. Emerging market economies have relaxed their fiscal stance in an attempt to tackle the health crisis, support people and firms, and offset the economic shocks. While more modest than that of advanced economies, these efforts were significantly greater than during the global financial crisis.
From conventional to unorthodox policies
Despite these actions, the outlook for emerging market economies remains clouded by considerable uncertainty. Chief among many risks is the possibility of a more prolonged health crisis, which would hurt more lives and could have dire economic consequences. Confronting a more severe downturn will be challenging because most emerging markets entered the current crisis with limited room for traditional fiscal, monetary, and external policy support. And much policy room has already been used up by actions undertaken in recent months.
Dwindling policy space may force some countries to take recourse to more unorthodox measures. From price controls and trade restrictions to more unconventional monetary policy and steps to ease credit and financial regulation. Some of these measures—which are also being implemented by some advanced and low-income economies—have significant costs, particularly if used intensively. Export restrictions, for example, could seriously distort the multilateral trading system, and price controls hamper the flow of goods to those who need it most.
The effectiveness of other unorthodox policies will depend on the credibility of the institutions; for instance, whether a country has a track record of credible monetary policy. As we navigate the contours of the ongoing crisis, little time is available to properly analyze the risks and benefits of these actions in a careful manner.
Not out of the woods yet
Emerging market economies have navigated the first phase of the crisis relatively well, but the next phase could be much more challenging. The virus remains present, financial conditions are still fragile, and policy space is lower, particularly for those countries facing high risks to debt sustainability. The latter group of countries is quite large. Approximately one third of all emerging market economies entered the crisis with high-debt levels and are assessed to have no space for undertaking additional discretionary fiscal policy, or as having that space significantly at risk.
Image courtesy of the IMF.
As the crisis develops, there is also a high risk that liquidity problems morph into solvency concerns. Besides sovereign debt stresses, corporate default risks are alarmingly high in a number of emerging market economies. Moreover, the crisis has hit poor people much harder, and this increase in inequality will amplify policy challenge in many countries.
The complexity of these challenges requires a multi-faceted policy response. First, domestic policies will need to be designed to allow for more durable and inclusive growth. Second, increased support from bilateral and multilateral lenders will be required where market access remains precarious. So far, the IMF has provided 22 emerging market economies with approximately $72 billion (SDR 52 billion) in financial assistance. Finally, for countries where debts prove to be unsustainable, timely and durable resolution of these problems will be needed, by seeking broad burden sharing across creditors including in the private sector. The latter two policy angles will be analyzed in two subsequent blogs on IMF lending and the IMF’s role in debt resolution.
AUTHORS:
Martin Mühleisen, Director of the Strategy, Policy, and Review Department (SPR) of the IMF
Tryggvi Gudmundsson, Economist in the IMF’s SPR
Hélène Poirson Ward, Deputy Division Chief in the IMF’s SPR
Compliments of the IMF.

Read More
EACC

US economic stimulus: what impact on household income?

In the wake of the Covid-19 crisis, the US authorities adopted an unprecedented set of fiscal measures, targeting households in particular. These measures aim at preserving the purchasing power of US households, but less than half of this additional income should be spent.

Chart 1. Compared fiscal policy responses 2020/2008, Source: Congressional Budget Office (CBO). Image courtesy of La Banque de France.
The Covid-19 crisis has led to a sharp deterioration in the US labour market
The coronavirus crisis has sent an unprecedented shockwave through the US labour market. Social distancing and other restrictions have paralysed many businesses, particularly in the service sector. Thus, the number of unemployment claims exploded between mid-March and the end of May 2020: 4 million on average per week, compared to around 220,000 in normal times. The rise in unemployment was very rapid, amounting in just two months to the equivalent of two years of job losses during the 2008-09 financial crisis.
The deterioration in the labour market required an urgent and forceful response from the US authorities. Especially given that household consumption remains the driving force behind the US economy and social safety nets are very minimal in the United States. For example, a significant difference between the US labour market and the European market is the lack of temporary job-retention schemes.
The impressive magnitude of the US package…
At the end of March, the US Congress adopted the Coronavirus Aid, Relief, and Economic Security Act (CARES), a vast economic assistance package of around USD 2.2 trillion, or 10% of GDP. This is the largest stimulus package in the history of the United States (see Chart 1). In addition, other support measures were introduced, totalling more than USD 2.7 trillion. During the 2008 financial crisis, fiscal measures amounted to USD 1.8 trillion, spread over 5 years. The magnitude is therefore greater today and the measures are concentrated on the last three quarters of 2020. The budget cost of these measures is estimated to exceed USD 2 trillion in 2020, excluding loan guarantees.

Chart 2. Stimulus decomposition by category targeted (for an estimated budget cost of USD 2050 bn) Source: CBO, BdF calculations. Image courtesy of La Banque de France.
While the measures target the economy as a whole, they are particularly aimed at households (60%, see Chart 2). Of particular note is the massive increase in unemployment insurance, in terms of amounts, eligibility criteria and duration. For example, an unemployed person will receive an additional USD 600 per week for up to 4 months. Other measures include direct payments to households of USD 1200 per individual, the introduction of paid sick leave in case of Covid-19, tax breaks, etc.
Furthermore, some schemes for businesses also aim to support employment. For instance, the Paycheck Protection Programme (PPP) provides SMEs with state-guaranteed loans that can be written off provided that 75% of the funds are used to pay salaries. This programme was widely and rapidly subscribed to.
… should compensate for the short-term loss of income
Using the NiGEM model, we carry out simulations to assess the impact of support measures on the income of US households and, more generally, on gross domestic product (GDP), in a Covid-19 shock scenario based on a single wave of contamination but with prolonged economic effects.
The disposable income of US households is not expected to be adversely affected in 2020 compared to its pre-crisis trend, as the stimulus measures should fully offset the loss of income caused by the Covid-19 crisis (see Chart 3). Households should even enjoy purchasing power gains (Real Personal Disposable Income – RPDI) thanks to lower inflation (see Table 1).

Chart 3. Impact of the Covid-19 shock and stimulus measures on household disposable income (% of pre-crisis trend) Source: BdF calculations (NiGEM simulations). Image courtesy of La Banque de France.
The increase in household disposable income in response to the different stimulus measures is already starting to be observed with a 13% increase in April compared to the previous month. This short-term rise is not surprising. It confirms the findings of recent microeconomic studies, such as Ganong et al, 2020, that estimate a median replacement rate of 134% for unemployment benefits, with two-thirds of eligible unemployed receiving benefits higher than their previous earnings.
In 2021, however, household disposable income is expected to contract compared to the pre-crisis trend, i.e. a negative shock of almost 3% on purchasing power, due to the relative persistence of unemployment and assuming that no new measures are taken.

TABLE 1. IMPACT OF STIMULUS ON HOUSEHOLD INCOME (% OF PRE-CRISIS SCENARIO)

2020

2021

 %

Covid-19 shock (without measures)

Impact of fiscal stimulus

Net change

Covid-19 shock (without measures)

Impact of fiscal stimulus

Net change

DISPOSABLE INCOME

-9.3

9.4

0.1

-12.4

6.6

-5.8

REAL DISPOSABLE INCOME

-8.0

8.9

0.9

-6.3

3.6

-2.7

Source: BdF calculations (NiGEM simulations)
Impact on GDP will depend on the savings behaviour of US households
Despite the relative stability of household income in 2020, it is not clear whether this replacement income will be fully spent, or even whether it will be spent in the same proportion as it was before the crisis. We assume that 40% of the additional income received by households would be consumed and the rest would be saved. All in all, the household savings rate is expected to average close to 20% in 2020, compared with an average of 8% in 2019.
This can be attributed to the high level of forced savings resulting from lockdown and changes in consumption habits; the savings rate reached a peak of 32% in April, after 8% in February and 13% in March. However, the households targeted by the stimulus payments mainly belong to the low-wage category, which traditionally have a higher propensity to consume and which, moreover, have benefited from a net increase in income (Muellbauer, 2020; Ganong et al., 2020). Furthermore, according to Karger and Rajan (2020), 48% of the cheques paid to households under the CARES Act were immediately consumed.
Overall, our results show that the stimulus should only partially absorb the shock to consumption and investment, thereby offsetting the loss of activity by 4.5 percentage points of GDP in 2020. Nevertheless, the US economy is expected to contract by between 6.5 and 8% in 2020 (according to our estimates as well as those of national and international institutions). The longer-term impact of these stimulus measures will depend on the consumption and savings behaviour of US households.
We analyse the sensitivity of our results to assumptions about the propensity of households to consume. With a lower marginal propensity to consume of 25%, similar to that observed during the recovery plans of 2001 and 2008 (Sham et al., 2010), the final gain in GDP would also be lower, i.e. around 3.4 percentage points.
The need for further stimulus measures is gradually becoming apparent
The measures were primarily taken by the US authorities in response to an emergency situation. Indeed, many of them are scheduled to end in July or at the end of the year. They are intended to temporarily make up for the lack of social safety nets and thus offset short-term income losses. However, they seem insufficient to allow the US economy to recover in the medium term, especially if the shock from the crisis proves to be relatively persistent. To this end, proposals have already been submitted to the US Congress on a new stimulus package to be adopted before the presidential election next November.
AUTHORS:
Annabelle de Gaye, CFA, Banque de France
Cristina Jude, Macroeconomist, Banque de France | cristina.jude[at]banque-france.fr
Compliments of La Banque de France.

EACC

Up-to-date report on the status of the Paycheck Protection Program (PPP) from the U.S. SBA

The Small Business Administration (SBA), in consultation with the Department of the Treasury, is providing this guidance to address borrower and lender questions concerning forgiveness of Paycheck Protection Program (PPP) loans, as provided for under section 1106 of the Coronavirus Aid, Relief, and Economic Security Act (CARES Act), as amended by the Paycheck Protection Program Flexibility Act (Flexibility Act). Borrowers and lenders may rely on the guidance provided in this document as SBA’s interpretation, in consultation with the Department of the Treasury, of the CARES Act, the Flexibility Act, and the Paycheck Protection Program Interim Final Rules (“PPP Interim Final Rules”).
Frequently Asked Questions For Loan Forgiveness  (Released 8/4/20)
Summary of PPP lending as of 7/31/20 (Released 8/3/20)
For more information, please reach out to the EACCNY or feel free to check out our COVID-19 Business Resources Section.
Compliments of the Small Business Administration.

Read More
EACC

IMF | Global Imbalances and the COVID-19 Crisis

The world entered the COVID-19 pandemic with persistent, pre-existing external imbalances. The crisis has caused a sharp reduction in trade and significant movements in exchange rates but limited reduction in global current account deficits and surpluses. The outlook remains highly uncertain as the risks of new waves of contagion, capital flow reversals, and a further decline in global trade still loom large on the horizon.
Our new External Sector Report shows that overall current account deficits and surpluses in 2019 were just below 3 percent of world GDP, slightly less than a year earlier. Our latest forecasts for 2020 imply only a further narrowing by some 0.3 percent of world GDP, a more modest decline than after the global financial crisis 10 years ago.
New trade barriers will not be effective in reducing imbalances.
The immediate policy priorities are to provide critical relief and promote economic recovery. Once the pandemic abates, reducing the world’s external imbalances will require collective reform efforts by both excess surplus and deficit countries. New trade barriers will not be effective in reducing imbalances.
Why imbalances matter
External deficits and surpluses are not necessarily a cause for concern. There are good reasons for countries to run them at certain points in time. But economies that borrow too much and too quickly from abroad, by running external deficits, may become vulnerable to sudden stops in capital flows. Countries also face risks from investing too much of their savings abroad given investment needs at home. The challenge lies in determining when imbalances are excessive or pose a risk. Our approach focuses on each country’s overall current account balance and not its bilateral trade balances with various trading partners, as the latter mainly reflect the international division of labor rather than macroeconomic factors.
We estimate that about 40 percent of global current account deficits and surpluses were excessive in 2019 and, as in recent years, concentrated in advanced economies. Larger-than-warranted current account balances were mostly in the euro area (driven by Germany and the Netherlands) with lower-than-warranted current account balances mainly existing among Canada, the United Kingdom, and the United States. China’s assessed external position remained, as in 2018, broadly in line with fundamentals and desirable policies, due to offsetting policy gaps and structural distortions.
Our report offers individual economy assessments of external imbalances and exchange rates for the 30 largest economies. Over time, these imbalances have accumulated, with the stocks of external assets and liabilities now at historic highs, potentially raising risks for both debtor and creditor countries. The persistence of global imbalances and mounting perceptions of an uneven playing field for trade has fueled protectionist sentiments, leading to a rise in trade tensions between the US and China. Overall, many countries had pre-existing vulnerabilities and remaining policy distortions heading into the crisis.
Image courtesy of the IMF.
COVID-19: An intense external shock
With the world economy still grappling with the COVID-19 crisis, the external outlook is highly uncertain. Even though we forecast a slight narrowing of global imbalances in 2020, the situation varies around the world. Economies dependent on severely affected sectors, such as oil and tourism, or reliant on remittances, could see a fall in their current account balances exceeding 2 percent of GDP. Such intense external shocks may have lasting effects and require significant economic adjustments. At the global level, our forecasts imply a more limited narrowing in current account balances than after the global financial crisis a decade ago, which partly reflects the smaller, precrisis global imbalances this time than during the housing and asset price booms of the mid-2000s.
Early in the COVID-19 crisis, tighter external financing conditions triggered sudden capital outflows with sharp currency depreciations across numerous emerging market and developing economies. The exceptionally strong fiscal and monetary policy responses, especially in advanced economies, have promoted a recovery in global investor sentiment since then, with some unwind of the initial sharp currency movements. But many risks remain, including new waves of contagion, economic scarring, and renewed trade tensions.
Another bout of global financial stress could trigger more capital flow reversals, currency pressures, and further raise the risk of an external crisis for economies with preexisting vulnerabilities, such as large current account deficits, a high share of foreign currency debt, and limited international reserves, as highlighted in this year’s analytical chapter. A worsening of the COVID-19 pandemic could also dislocate global trade and supply chains, reduce investment, and hinder the global economic recovery.
Image courtesy of the IMF.
Providing relief and rebalancing the world economy
Policy efforts in the near term should continue to focus on providing lifelines and promoting economic recovery. Countries with flexible exchange rates would benefit from continuing to allow them to adjust in response to external conditions, where feasible. Foreign exchange intervention, where needed and where reserves are adequate, could help alleviate disorderly market conditions. For economies facing disruptive balance of payments pressures and without access to private external financing, official financing and swap lines can help provide economic relief and preserve critical health care spending.
Tariff and nontariff barriers to trade should be avoided, especially on medical equipment and supplies, and recent new restrictions on trade rolled back. Using tariffs to target bilateral trade balances is costly for trade and growth, and tends to trigger offsetting currency movements. Tariffs are also generally ineffective for reducing excess external imbalances and currency misalignments, which requires addressing underlying macroeconomic and structural distortions. Modernizing the multilateral rules-based trading system and strengthening rules on subsidies and technology transfer is warranted, including by expanding the rule book on services and e-commerce and ensuring a well-functioning WTO dispute settlement system.
Over the medium term, reducing excess imbalances in the global economy will require joint efforts on the part of both excess surplus and excess deficit countries. Economic and policy distortions that predated the COVID-19 crisis might persist or worsen, suggesting the need for reforms tailored to country-specific circumstances.
In economies where excess current account deficits before the crisis reflected larger-than-desirable fiscal deficits (as in the United States) and where such imbalances persist, fiscal consolidation over the medium term would promote debt sustainability, reduce the excess current account gap, and facilitate raising international reserves where needed (as in Argentina). Countries with export competitiveness challenges would benefit from productivity-raising reforms.
In economies where excess current account surpluses that existed before the crisis persist, prioritizing reforms that encourage investment and discourage excessive private saving are warranted. In economies with remaining fiscal space, a growth-oriented fiscal policy would strengthen economic resilience and narrow the excess current account surplus. In some cases, reforms to discourage excessive precautionary saving may also be warranted (as in Thailand and Malaysia) including by expanding the social safety net.
AUTHORS
Martin Kaufman, Assistant Director in the Strategy, Policy and Review Department, IMF
Daniel Leigh, Deputy Division Chief in the Western Hemisphere Department, IMF
Compliments of the IMF.